About
I am a Senior Lecturer in Clinical Microbiology at the University of Derby, where I am actively engaged in both teaching and research across undergraduate and postgraduate programmes. My academic and research interests are rooted in clinical microbiology and virology, with a particular emphasis on infectious diseases, viral hepatitis, and post-viral syndromes such as Long COVID.
Before joining the University of Derby, I taught and conducted research at the Kamuzu University of Health Sciences in Malawi, where I was promoted to the rank of Associate Professor of Medical Microbiology following a successful application. In addition to my teaching and research responsibilities, I have secured several grants both as Principal Investigator and Co-Investigator particularly during my tenure in Malawi. My professional contributions have played a significant role in shaping policy within the Government of Malawi. While at the University of Derby, I have submitted some grant applications and continue to pursue funding opportunities to support impactful research and development initiatives.
I was honoured to receive a prestigious Commonwealth Scholarship, which enabled me to pursue Medical Microbiology studies at the University of Liverpool. I subsequently obtained my PhD in Medical Microbiology/Virology at the University of Plymouth, in collaboration with Imperial College London, through a PhD scholarship. I later held a Postdoctoral Research Associate (PDRA) position supported by a joint award from the Wellcome Trust and the University of Malawi.
At the University of Derby, I am currently collaborating with Professor Mark Faghy on a robust research platform aimed at identifying the underlying mechanisms of Long COVID. This work is focused on exploring the clinical, immunological, and cellular features of patients affected by COVID-19, in order to improve our understanding of the pathology and inform future treatment strategies.
I am currently supervising two PhD students who are in the final stages of their research. I welcome enquiries from prospective PhD candidates interested in clinical microbiology, virology, viral hepatitis, or the investigation of post-viral conditions such as Long COVID.
Alongside my research activities, I lead a range of teaching modules across undergraduate and postgraduate programmes, contributing to curriculum development and student mentorship.
Teaching responsibilities
I am responsible for leading the Medical Microbiology course within the Department of Biomedical and Forensic Sciences, delivered at both undergraduate and postgraduate levels. My role involves the full design and delivery of course content, ensuring that the module meets academic and professional standards. I also implement both summative and formative assessments, and provide constructive, timely feedback and feedforward to support student development.
As part of my academic responsibilities, I also serve as a personal academic tutor, offering individual guidance and pastoral support to students throughout their studies.
Modules I currently contribute to include:
- (4BY536) Introduction to Biomedical Science
- (5BY543) Microbiology
- (5BY544) Clinical Immunology
- (5BY545) Diagnostic Molecular Biology
- (5BY546) Haematology
- (6BY529) Medical Microbiology
- (6BY993) Research Project (Undergraduate)
- (7FO999) Research Project (Postgraduate)
- (7EL996) Independent Scholarly Activity
- (7BY511) Applied Microbial Biotechnology
- (7BY514) Applied Immunology
Through these teaching activities, I aim to foster critical thinking, scientific curiosity, and research-led learning in the next generation of biomedical scientists. My teaching is closely complemented by professional interests that focus on fostering multidisciplinary collaborations and advancing medical microbiology research.
Professional interests
My professional interests encompass curriculum development for medical and allied health programmes. I am deeply committed to advancing research and teaching in these areas, and I remain open to continuous learning, collaboration, and exploring new roles that foster professional growth and innovation. I am committed to mentoring academic staff and postgraduate students, engaging in public health education, and collaborating with other professionals. I will play an active role in academic leadership through participation in institutional committees, supporting accreditation and educational excellence.
I am deeply committed to fostering collaboration with like-minded individuals across academic, non-academic, and industrial sectors, particularly those who share a multidisciplinary approach to research and practice.
A significant part of my professional focus, both nationally and internationally, is dedicated to building strong professional networks and research collaborations with an emphasis on securing competitive research grants. I am keen to attract highly motivated PhD candidates to contribute to our growing multidisciplinary research efforts.
Research interests
My primary interests lie in medical microbiology, viral immunology, infectious diseases, and molecular microbiology especially in exploring the immunological and molecular mechanisms underlying microbial pathogenesis.
I am broadly interested in host–viral interactions, with a focus on understanding viral pathogenesis and the immune responses they elicit. During my PhD studies, I had the privilege of conducting part of the research at Imperial College London’s South Kensington campus, which provided an excellent opportunity to develop valuable research skills within a world-class institution. Throughout this period, I enhanced my expertise in metabonomics, experimental design, creativity, and critical thinking. My programme involved practical experience with Liquid Chromatography Mass Spectrometry (LC/MS) techniques, including data analysis and interpretation. I gained invaluable insight from leading experts committed to innovation.
My doctoral research primarily centred on characterising hepatitis C virus (HCV) resistance and investigating possible immunological mechanisms protecting HCV-exposed but uninfected individuals. Specifically, I explored the role of viral–lipid interactions and the innate immune response in conferring resistance to infection in this population. Over the years, I have acquired essential transferable skills in molecular techniques and immunology, including cell culture, ELISPOT, ELISA, Luminex assays, and Polymerase Chain Reaction (PCR) methods. During my Postdoctoral Research Associate award, funded by the Wellcome Trust, I studied rotavirus-specific B cell subsets in children under five presenting with gastroenteritis at Queen Elizabeth Central Hospital in Blantyre, Malawi. This work provided me with hands-on immunological phenotyping experience, including the use of FlowJo software for analysis of flow cytometry data (BD LSRFortessa).
My current research centres on understanding the pathogenesis and mechanisms of Long COVID; as well as the immunological and molecular signatures of viral hepatitis and HCC development. In addition, I actively welcome collaborations and PhD proposals related to viral hepatitis, particularly in projects that align with our core themes in microbiology and host-pathogen interactions.
My core research interests delve into viral pathogenesis and immune responses, building upon skills and knowledge gained during my PhD and postdoctoral studies.
To support and stay current in my field, I actively participate in several professional organisations and scientific societies.
Membership of professional bodies
- Fellow of the Institute of Biomedical Sciences (FIBMS) UK
- British Association for the Study of the Liver Disease (BASL)
- Microbiology Society
- Member of the Medical Council of Malawi
- Member of the American Society for Microbiology
Qualifications
- PhD Medical Microbiology/Virology – University of Plymouth, UK
- MSc Medical Microbiology – University of Liverpool, UK
- General Teaching Associate (GTA) – University of Plymouth, UK
Engagement in national and international conferences allows me to disseminate my research findings and stay connected with developments in clinical microbiology.
Recent conferences
- Delphin, Marion; Waddilove, Elizabeth; Kreuels, Benno; Shawa, Isaac T.; Silungwe, Niza M.; mbale, blessings; et al. (2025). Immune Insights from Malawi: The Dual Challenge of HBV and Liver Disease. figshare. Poster. https://doi.org/10.6084/m9.figshare.28632647.v. At: Global Health Summit 2025, Los Angeles, USA.
- Chimberenga, S., Mgawa, A., James, G., Jumbe, E., Van Hout, MC., Nyirenda, M., Shawa, IT. Unsafe Sexual practice prior to incarceration, a high-risk factor of HBV and HIV infection among prisoners in Blantyre, Malawi. International Network on Health and Hepatitis in Substance Users (INHSU) Conference, Geneva Switzerland, 2023
- Stockdale, A., Kreuels, B., Shawa, I., Silungwe, N., Chetcuti, K., Joekes, E., Mbale, B., Mallewa, J., Tannich, E., Weiler-Normann, C. and Lüetgehetman, M., 2023. P34 Aetiology and outcomes of cirrhosis and hepatocellular carcinoma in Blantyre, Malawi
- Stockdale AJ, Kreuels B, Shawa IT, Geretti AM, Gordon MA. Aetiology and outcomes of cirrhosis and hepatocellular carcinoma (HCC) in Queen Elizabeth Central Hospital (QECH), Blantyre, Malawi. Conference on Liver Disease in Africa (COLDA) (Digital). Sept 2020.
- Stockdale AJ, Silungwe NM, Shawa IT, Kreuels B, Everett D, Gordon MA, Geretti AM. Performance of hepatitis B e antigen (HBeAg) rapid diagnostic tests (RDTs) in Malawi: A comparative evaluation in community and inpatient populations with hepatitis B virus (HBV). Conference on Liver Disease in Africa (COLDA) (Digital). Sept 2020.
- Stockdale AJ, Meiring J, Shawa IT, Thindwa D, Silungwe N, Mbewe M, Mitambo C, Kachala R, Kreuels B, Patel P, Patel P, Gordon SB, Geretti AM, Gordon MA. Evaluation of hepatitis B virus (HBV) epidemiology, vaccine impact and treatment eligibility: a census-based community serological survey in Blantyre, Malawi. International Liver Congress: European Association for the Study of the Liver (Digital). Journal of Hepatology; 2020: 73:S790: abstract SAT274, page S790:
- Stockdale AJ, Shawa I, Everett D, Geretti AM, Gordon MA. Epidemiology of hepatitis B and evaluation of vaccine efficacy in a census-based community serosurvey of Ndriande township in Blantyre, Malawi. 11th European Congress on Tropical Medicine and International Health, Liverpool, UK. Abstract published in Trans R Soc Trop Med Hyg 2019;113:S225
- Stockdale A, Meiring J, Shawa IT, Thindwa D, Silungwe N, Mbewe M, Mitambo C, Kachala R, Kreuels B, Patel P, Patel P. Evaluation of hepatitis B virus (HBV) epidemiology, vaccine impact and treatment eligibility: a census-based community serological survey in Blantyre, Malawi. Journal of Hepatology. 2020 Aug 1;73:S790
- Bassendine M, Pagano S, Bridge S, Sheridan D, Shawa I, Cramp M, et al. SAT-221-Autoantibodies to apolipoprotein A1 (apoA-1): A new prognostic biomarker in HCV infection. J Hepatol. 2019
- Shawa I., Bennett K, Sheridan D, et al. Upregulated innate immune responses in a hepatitis C virus-exposed uninfected cohort. J Hepatol 2018;68:S798. doi:10.1016/S0168-8278(18)31867-1. France. Poster
- Shawa IT, Cox IJ, Riva A, et al. Urine Metabolic Profiling Distinguishes HCV-Exposed Uninfected Injection Drug Users From Those With Chronic Or Resolved HCV Infection. In: British Association for the study of the Liver Annual Meeting. 2016. Manchester, UK. Poster
- Shawa IT, Gomez Romero M, Pechlivanis A, et al. Serum lipid profiling using Ultra-performance liquid chromatography mass spectrometry (UPLC/MS) discriminates HCV-exposed uninfected injection drug users from those susceptible to infection. In: British Association for the study of the Liver. 2016. Manchester, UK. Poster
- Sheridan DA, Gomez Romero M, Bridge S, Crossey M, Shawa IT, Neely D, Felmlee D, Holmes E, Bassendine M, Taylor-Robinson S. P0725 : Lipidomics analysis of fasting serum identifies novel lipid biomarkers specific for HCV genotype 3 and genotype 1 chronic hepatitis C virus infection. J Hepatol [Internet] 2015;62:S596 [DOI: 10.1016/S0168-8278(15)30928-4]; Spain. Poster
Experience in industry
I previously served as a Lecturer, Senior Lecturer at the University of Malawi College of Medicine (now Kamuzu University of Health Sciences), where I spent several years contributing to academic leadership, research, and programme development. I was later promoted to the rank of Associate Professor of Medical Microbiology, following a successful application, recognising my contributions to teaching, research, and leadership, and service.
During my time at the University of Malawi, I held several significant roles, including:
- Head of Department
- Member, Research Ethics Committee (Central Institutional Review Board)
- Faculty/College Representative, University Senate Committee (Academic Board)
- Module and Programme Leader, as well as Research Coordinator
- Postdoctoral Research Fellow, funded by the Wellcome Trust
- Country Ambassador to Malawi, American Society for Microbiology (ASM)
In addition to my academic responsibilities, I completed two important consultancy projects funded by international organisations:
- Improving Turnaround Time for Malaria Testing at Malawi Blood Transfusion Service (MBTS) – Funded by the CDC (Accepted).
- Implementation of HIV Supplementary/Confirmatory Testing System for MBTS – Funded by the EU (Accepted).
I was also actively involved in national response efforts during the COVID-19 pandemic. When the first case of SARS-CoV-2 was reported in Malawi, I participated in molecular diagnostics and provided professional guidance to communities. I contributed to public health outreach through media engagements, helping to dispel misinformation and address concerns around COVID-19 vaccination through television and radio interviews.
I have gained valuable experience in grant writing through collaborative research projects in Malawi, where I successfully secured funding both as a Principal investigator, and a co-investigator on several grants. These projects focused on clinical microbiology and infectious diseases. I have also contributed to grant applications while based in the UK, further strengthening my skills in proposal development and international research collaboration.
I have also pursued extensive international opportunities, including invited talks, training, and collaborative projects to broaden my expertise and networks.
International experience
- In 2025, I was honoured to be invited as a visiting Professor to Jomo Kenyatta University of Agriculture and Technology in Nairobi, Kenya, where I delivered a series of talks and shared my professional experience. The presentations were well received, and the visit laid the groundwork for ongoing international collaborations focused on knowledge exchange, joint research, grant writing, innovation, staff and student mobility, and capacity building.
- I was awarded a Travel Grant by the Norwegian Agency for Development Cooperation (NORAD) to visit the University of Tromsø in Tromsø, Norway, where I undertook specialised training in molecular virology research techniques.
- I completed a two-week intensive training programme in viral diagnostics and research at CAVIDI in Uppsala, Sweden, focusing on HIV reverse transcriptase (RT) viral load and drug resistance determination.
- Through a DELPHE Travel Grant funded by the UK Department for International Development (DFID), I visited Ninewells Hospital in Dundee, Scotland, where I observed diagnostic medical virology practices, including laboratory workflows, diagnostic protocols, and clinical applications.
- Earlier in my career, I undertook medical diagnostic instrumentation training at Mindray in Shenzhen, China, which enhanced my understanding of automation and diagnostic technologies.
- I have presented my research at an international conference in Geneva, Switzerland.
- I have also participated in numerous trainings, workshops, and scientific meetings in the United Kingdom, South Africa, and Malawi, supporting my continuous professional development and regional networking.
In addition to my research and teaching, I actively engage with the scientific community through editorial responsibilities and committee memberships.
Additional interests and activities
- Editorial Board Member – BMC Infectious Diseases (Springer Nature).
- Editorial Board Member – African Journal of Respiratory Medicine.
- Guest Editor – Journal of Tropical Medicine and Infectious Diseases (MDPI).
- Guest Editor – BMC Infectious Diseases (Springer Nature).
- Reviewer – Discover Viruses (Springer Nature).
- Reviewer – BMC Infectious Diseases (Springer Nature).
- Reviewer – Scientific Reports (Springer Nature).
- Book Editor – Iterative International Publishers (IIPSeries).
- Book Editor – Bentham Science Publishers.
- Member – University Ethics Committee, University of Derby.
- Mentor and Supervisor – PhD and early-career researchers.
- Grant Collaborator – for international research funders.
- Public Engagement – Expert media commentary and community outreach on infectious diseases and vaccine awareness.
- Capacity Building – In diagnostics, research ethics, and laboratory systems in low- and middle-income countries.
- Professional Membership – Including the British Association of the Study of the Liver Disease (BASL), Malawi Medical Council, Institute of Biomedical Science (IBMS), Microbiology Society, and American Society for Microbiology (ASM), with past service as Country Ambassador to Malawi.
Hobbies:
- Travelling and meeting new people, which continually enrich my global perspective and interpersonal skills.
- Sporting activities - Football, Volleyball etc.
- Group fitness sessions.
- Mindful walking.
I have made several appearances in mainstream media outlets in Malawi, providing expert commentary on a range of public health topics including COVID-19, HIV, viral hepatitis, and other infectious diseases. Through television and radio interviews, I have contributed to public education, addressed misinformation, and supported national efforts in disease awareness and prevention.
My research endeavours have been supported by various grants, reflecting my commitment to advancing knowledge in clinical microbiology and infectious diseases.
Recent publications
2025
- Stockdale AJ, Kreuels B, Shawa IT, Silungwe NM, Mbale B, Chetcuti K, Joekes E, Mallewa J, Tannich E, Weiler-Normann C, Lütgehetmann M. Causes, associated exposures, and outcomes of cirrhosis and hepatocellular carcinoma in Malawi: an observational cohort and case–control study. The Lancet Global Health. 2025 Nov 1;13(11):e1924-34
-
Maluwa, T., Dinala, Y., Gadama, L., Shawa, IT. Evaluation of Immunosuppressive Status Among HIV-Positive Women With Cervical Cancer at Queen Elizabeth Central Hospital, Malawi. Medicine Advances: 1-8.
- Nkhata CB, Stockdale AJ, Mvula MN, Kalongonda MM, Masamba M, Shawa IT. Epidemiology of hepatitis B and C viruses among pregnant women at Queen Elizabeth Central Hospital(QECH), Blantyre Malawi. Malawi Medical Journal. 2025, Sept 18.
- Bridge SH, Pagano S, Lodge JK, Shawa IT, Marin-Crespo P, Cramp ME, Sheridan DA, Taylor-Robinson SD, Vuilleumier N, Neely RDG and Bassendine MF (2025) Autoantibodies to apolipoprotein A-I in hepatitis C virus infection: a role in disease progression? Immunol. 16:1461041. doi: 10.3389/fimmu.2025.1461041
- Chimberenga, S., Phiri, V., Mgawa, A., James, G., Jumbe, E., Van Hout, M., Nyirenda, M., Shawa, IT. Unsafe sexual practices prior to incarceration, and early childhood transmission are potential high-risk factors of Hepatitis B and HIV infection among prisoners in Blantyre, Malawi..Microbes and Infectious Diseases, 2025; 6(1): 110-122. doi: 10.21608/mid.2024.308772.212
- Callum Thomas, Massimo Nunes, Jan H. Pretorius, Ruth EM Ashton, Isaac T. Shawa, Tom Bewick, Etheresia Pretorius, Douglas B. Kell, Mark A. Faghy. Exercise-induced Changes in Microclotting and Cytokine Levels Point to Vascular Injury and Inflammation in People with Long COVID, 26 May 2025, PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-6717727/v1].
- Chawinga, K.; Hang’ombe, B. M.; Mainda, G.; Mbaimbai, F.; Kabwali, E.; Goma, F. Y.; Muuka, G.; Munyeme, M.; Mkakosya, R. S.; Shawa, I. T. Comparative Analysis of Antimicrobial Susceptibility Profiles of Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolated from Intensively Reared and Free-Range Chickens in Selected Districts of Zambia. Preprints 2025, 2025080219. https://doi.org/10.20944/preprints202508.0219.v1.
2024
- Madhlopa, Q.K., Mtumbuka, M., Kumwenda, J., Illingworth, T.A., Van Hout, M.C., Mfutso-Bengo, J., Mikeka, C. and Shawa, I.T., 2024. Factors affecting COVID-19 vaccine uptake in populations with higher education: insights from a cross-sectional study among university students in Malawi. BMC Infectious Diseases, 24(1), p.848
- Shawa, I.T., 2024. Antiviral properties of cannabidiol for the management of COVID-19. In Cannabis and Khat in Drug Discovery (pp. 137-151). Elsevier Science
- Guraka, A., Mierlea, S., Drake, S.J., Shawa, I.T., Waldron, J., Corcoran, M., Dowse, D., Walkman, D., Burn, L., Sivasubramaniam, S. and Kermanizadeh, A., 2024. A comprehensive toxicological analysis of panel of unregulated e-cigarettes to human health. Toxicology, 509, p.153964
- Lazarus, J.V., Mark, H.E., Allen, A.M., Arab, J.P., Carrieri, P., Noureddin, M., Alazawi, W., Alkhouri, N., Alqahtani, S.A., Anstee, Q.M. and Arrese, M., 2024. A global action agenda for turning the tide on fatty liver disease. Hepatology, 79(2), pp.502-523
- Fouad, Y., Ghazinyan, H., Alboraie, M., Al Khatry, M., Desalegn, H., Al-Ali, F., El-Shabrawi, M.H., Ocama, P., Derbala, M., Barakat, S. and Awuku, Y.A., 2024. Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition. Journal of Hepatology, 80(5), pp.e194-e197
2023
- Allison, R., Guraka, A., Shawa, I.T., Tripathi, G., Moritz, W. and Kermanizadeh, A., 2023. Drug induced liver injury–a 2023 update. Journal of Toxicology and Environmental Health, Part B, pp.1-26
- Lazarus, J.V., Mark, H.E., Allen, A.M., Arab, J.P., Carrieri, P., Noureddin, M., Alazawi, W., Alkhouri, N., Alqahtani, S.A., Arrese, M. and Bataller, R., 2023. A global research priority agenda to advance public health responses to fatty liver disease. Journal of hepatology, 79(3), pp.618-634
2022
- Méndez-Sánchez, N., Bugianesi, E., Gish, R.G., Lammert, F., Tilg, H., Nguyen, M.H., Sarin, S.K., Fabrellas, N., Zelber-Sagi, S., Fan, J.G. and Shiha, G., 2022. Global multi-stakeholder endorsement of the MAFLD definition. The Lancet Gastroenterology & Hepatology, 7(5), pp.388-390
- Lazarus, J.V., Mark, H.E., Villota-Rivas, M., Palayew, A., Carrieri, P., Colombo, M., Ekstedt, M., Esmat, G., George, J., Marchesini, G. and Novak, K., 2022. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?. Journal of Hepatology, 76(4), pp.771-780
- Stockdale, A.J., Meiring, J.E., Shawa, I.T., Thindwa, D., Silungwe, N.M., Mbewe, M., Kachala, R., Kreuels, B., Patel, P., Patel, P. and Henrion, M.Y., 2022. Hepatitis B vaccination impact and the unmet need for antiviral treatment in Blantyre, Malawi. The Journal of infectious diseases, 226(5), pp.871-880
- Mhango, C., Mandolo, J.J., Chinyama, E., Wachepa, R., Kanjerwa, O., Malamba-Banda, C., Matambo, P.B., Barnes, K.G., Chaguza, C., Shawa, I.T. and Nyaga, M.M., 2022. Rotavirus genotypes in hospitalized children with acute gastroenteritis before and after rotavirus vaccine introduction in Blantyre, Malawi, 1997–2019. The Journal of infectious diseases, 225(12), pp.2127-2136
- Sheridan, D.A., Shawa, I.T., Thomas, E.L., Felmlee, D.J., Bridge, S.H., Neely, D., Cobbold, J.F., Holmes, E., Bassendine, M.F. and Taylor-Robinson, S.D., 2022. Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis. Scientific reports, 12(1), pp.1-11
- Benedicto-Matambo, P., Bines, J.E., Malamba-Banda, C., Shawa, I.T., Barnes, K., Kamng’ona, A.W., Hungerford, D., Jambo, K.C., Iturriza-Gomara, M., Cunliffe, N.A. and Flanagan, K.L., 2022. Leveraging Beneficial Off-Target Effects of Live-Attenuated Rotavirus Vaccines. Vaccines, 10(3), p.418
- Stockdale, A.J., Kreuels, B., Shawa, I.T., Meiring, J.E., Thindwa, D., Silungwe, N.M., Chetcuti, K., Joekes, E., Mbewe, M., Mbale, B. and Patel, P., 2022. A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi, suggests a historic mechanism of transmission. Journal of Viral Hepatitis, 29(4), pp.252-262
2021
- Sheridan DA, Shawa IT, Thomas EL, et al. Lipidomics and body fat composition analysis characterises specific differences in cholesterol metabolism and steatosis between hepatitis C virus genotypes 1 and 3. Research Square; 2021. DOI: 10.21203/rs.3.rs-990460/v1
- Lazarus JV, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, Cortez-Pinto H, Crespo J, Cusi K, Dirac MA, Francque S. Advancing the global public health agenda for NAFLD: a consensus statement. Nature Reviews Gastroenterology & Hepatology. 2021 Oct 27:1-9
- Mandolo, J.J., Henrion, M.Y., Mhango, C., Chinyama, E., Wachepa, R., Kanjerwa, O., Malamba-Banda, C., Shawa, I.T., Hungerford, D., Kamng’ona, A.W. and Iturriza-Gomara, M., 2021. Reduction in severity of all-cause gastroenteritis requiring hospitalisation in children vaccinated against rotavirus in Malawi. Viruses, 13(12), p.2491
- Stockdale, A.J., Silungwe, N.M., Shawa, I.T., Kreuels, B., Gordon, M.A. and Geretti, A.M., 2021. Diagnostic performance evaluation of hepatitis B e antigen rapid diagnostic tests in Malawi. BMC infectious diseases, 21(1), pp.1-10
2020
- Munharo, S., Nayupe, S., Mbulaje, P., Patel, P., Banda, C., Gacutno, K.J.A., Lin, X. and Shawa, I.T., 2020. Challenges of COVID-19 testing in low-middle income countries (LMICs): the case of Malawi. Journal of Laboratory and Precision Medicine, 5(10.21037)
2017
- Shawa, I.T., Felmlee, D.J., Hegazy, D., Sheridan, D.A. and Cramp, M.E., 2017. Exploration of potential mechanisms of hepatitis C virus resistance in exposed uninfected intravenous drug users. Journal of Viral Hepatitis, 24(12), pp.1082-1088
- Shawa, I.T., Sheridan, D.A., Felmlee, D.J. and Cramp, M.E., 2017. Lipid interactions influence hepatitis C virus susceptibility and resistance to infection. Clinical Liver Disease, 10(1), p.17
- Chipetah, F., Chirambo, A., Billiat, E. and Shawa, I.T., 2017. Hepatitis B virus seroprevalence among Malawian medical students: a cross-sectional study. Malawi Medical Journal, 29(1), pp.29-31
Book and Book Chapter Authorship
Books:
- Prajapati, A. K., & Shawa, I. T. (Eds.). (2025). Novel diagnostic methods in clinical microbiology. Iterative International Publishers. ISBN 978-93-7020-267-2.
Book Chapters:
- Shawa, I.T., 2025. Diagnostic approaches for biofilm-associated infections. In: A.K. Prajapati and I.T. Shawa, eds., Novel diagnostic methods in clinical microbiology. Iterative International Publishers, pp. 123–145. Available at: https://doi.org/10.58532/nbennurNDMCSW10
- Shawa, I.T., 2024. Antiviral properties of cannabidiol for the management of COVID-19. In Cannabis and Khat in Drug Discovery (pp. 137-151). Elsevier Science.
- Shawa, I.T., 2019. Hepatitis B and C viruses. In Hepatitis B and C. IntechOpen.